WINDTREE THERAPEUTICS INC /DE/
WINT
Transaktioner
126
Köp
112
Sälj
14
Nettoinsynsflöde
3.0 mn USD
Köpvärde minus säljvärde
Rapportanalys
Senast rapporterade siffror, automatiskt granskadeLäser senaste rapporten…
Aktiekurs och insynstransaktioner
Ingen prisdata ännuIngen prisserie har matchats mot detta bolag ännu.
Avkastning efter transaktion
Median-% efter transaktionsdatumKursserien för detta bolag rör sig i tick som är stora i förhållande till aktiekursen, så procentuell avkastning skulle domineras av avrundningsbrus snarare än av verkliga kursrörelser. Avkastningsstatistik visas därför inte.
Signalkorrelation
Månatligt nettoinsynsflöde vs avkastning–
Pearsonkorrelation mellan den signerade logaritmen av månatligt nettoinsynsköp och den månadens aktiekursavkastning, över 0 månader med aktivitet. Värden nära noll innebär att insynsflödet inte gav någon timinginformation för detta bolag.
Alla rapporterade transaktioner
126 rader| Datum | Person | Position | Typ | Volym | Pris | Värde |
|---|---|---|---|---|---|---|
| 2024-10-08 | Fraser Craig | President and CEO | Buy | 5 k | 0,91 | 5 k USD |
| 2024-10-08 | Fraser Craig | President and CEO | Buy | 5 k | 0,91 | 5 k USD |
| 2023-09-27 | Fraser Craig | President and CEO | Buy | 3 k | 1,02 | 3 k USD |
| 2023-09-27 | Fraser Craig | President and CEO | Buy | 3 k | 1,02 | 3 k USD |
| 2023-09-26 | Fraser Craig | President and CEO | Buy | 3 k | 0,90 | 2 k USD |
| 2023-09-26 | Fraser Craig | President and CEO | Buy | 3 k | 0,90 | 2 k USD |
| 2023-08-23 | Geffken Daniel E. | Director | Buy | 2 k | 0,00 | 0 USD |
| 2023-08-23 | Geffken Daniel E. | Director | Buy | 2 k | 0,00 | 0 USD |
| 2023-08-23 | Curtis Eric | SVP & COO | Buy | 15 k | 0,00 | 0 USD |
| 2023-08-23 | Fraser Craig | President and CEO | Buy | 46 k | 0,00 | 0 USD |
| 2023-08-23 | SCOTT ROBERT A | Director | Buy | 2 k | 0,00 | 0 USD |
| 2023-08-23 | Simonson Steven | SVP, Chief Medical Officer | Buy | 16 k | 0,00 | 0 USD |
| 2023-08-23 | Strobeck Mark | Director | Buy | 2 k | 0,00 | 0 USD |
| 2023-08-23 | Fraser Craig | President and CEO | Buy | 46 k | 0,00 | 0 USD |
| 2023-08-23 | Curtis Eric | SVP & COO | Buy | 15 k | 0,00 | 0 USD |
| 2023-08-23 | Simonson Steven | SVP, Chief Medical Officer | Buy | 16 k | 0,00 | 0 USD |
| 2023-08-23 | SCOTT ROBERT A | Director | Buy | 2 k | 0,00 | 0 USD |
| 2023-08-23 | Strobeck Mark | Director | Buy | 2 k | 0,00 | 0 USD |
| 2023-08-23 | Williams Leslie J. | Director | Buy | 2 k | 0,00 | 0 USD |
| 2023-08-23 | Williams Leslie J. | Director | Buy | 2 k | 0,00 | 0 USD |
| 2023-04-26 | Fraser Craig | President and CEO | Buy | 1 k | 1,77 | 3 k USD |
| 2023-04-26 | Fraser Craig | President and CEO | Buy | 1 k | 1,77 | 3 k USD |
| 2023-04-25 | Fraser Craig | President and CEO | Buy | 1 k | 1,89 | 2 k USD |
| 2023-04-25 | Fraser Craig | President and CEO | Buy | 1 k | 1,89 | 2 k USD |
| 2023-02-28 | CARMAN DIANE | SVP & General Counsel | Sell | 99 | 0,00 | 0 USD |
| 2023-02-28 | Curtis Eric | SVP & COO | Sell | 99 | 0,00 | 0 USD |
| 2023-02-28 | Fraser Craig | President and CEO | Sell | 334 | 0,00 | 0 USD |
| 2023-02-28 | Simonson Steven | SVP, Chief Medical Officer | Sell | 100 | 0,00 | 0 USD |
| 2023-02-28 | CARMAN DIANE | SVP & General Counsel | Sell | 99 | 0,00 | 0 USD |
| 2023-02-28 | Curtis Eric | SVP & COO | Sell | 99 | 0,00 | 0 USD |
| 2023-02-28 | Fraser Craig | President and CEO | Sell | 334 | 0,00 | 0 USD |
| 2023-02-28 | Simonson Steven | SVP, Chief Medical Officer | Sell | 100 | 0,00 | 0 USD |
| 2023-02-22 | Huang James | Director | Buy | 1.1 mn | 0,14 | 157 k USD |
| 2023-02-22 | Huang James | Director | Buy | 1.1 mn | 0,14 | 157 k USD |
| 2022-07-27 | Fraser Craig | President and CEO | Buy | 3 k | 0,38 | 950 USD |
| 2022-07-27 | Fraser Craig | President and CEO | Buy | 3 k | 0,38 | 950 USD |
| 2022-07-26 | Fraser Craig | President and CEO | Buy | 3 k | 0,37 | 935 USD |
| 2022-07-26 | Hamill John P. | SVP & CFO | Buy | 3 k | 0,37 | 1 k USD |
| 2022-07-26 | Fraser Craig | President and CEO | Buy | 3 k | 0,37 | 935 USD |
| 2022-07-26 | Hamill John P. | SVP & CFO | Buy | 3 k | 0,37 | 1 k USD |
| 2022-06-30 | Fraser Craig | President and CEO | Buy | 5 k | 0,43 | 2 k USD |
| 2022-06-30 | Fraser Craig | President and CEO | Buy | 5 k | 0,43 | 2 k USD |
| 2022-06-29 | Fraser Craig | President and CEO | Buy | 7 k | 0,42 | 3 k USD |
| 2022-06-29 | Fraser Craig | President and CEO | Buy | 7 k | 0,42 | 3 k USD |
| 2022-06-07 | Geffken Daniel E. | Director | Buy | 5 k | 0,00 | 0 USD |
| 2022-06-07 | Huang James | Director | Buy | 5 k | 0,00 | 0 USD |
| 2022-06-07 | SCOTT ROBERT A | Director | Buy | 5 k | 0,00 | 0 USD |
| 2022-06-07 | Geffken Daniel E. | Director | Buy | 5 k | 0,00 | 0 USD |
| 2022-06-07 | Huang James | Director | Buy | 5 k | 0,00 | 0 USD |
| 2022-06-07 | SCOTT ROBERT A | Director | Buy | 5 k | 0,00 | 0 USD |
| 2022-06-07 | Williams Leslie J. | Director | Buy | 5 k | 0,00 | 0 USD |
| 2022-06-07 | Williams Leslie J. | Director | Buy | 5 k | 0,00 | 0 USD |
| 2022-03-16 | Fraser Craig | President and CEO | Buy | 2 k | 0,98 | 2 k USD |
| 2022-03-16 | Fraser Craig | President and CEO | Buy | 2 k | 0,98 | 2 k USD |
| 2022-03-15 | Fraser Craig | President and CEO | Buy | 3 k | 0,98 | 3 k USD |
| 2022-03-15 | Simonson Steven | SVP, Chief Medical Officer | Buy | 5 k | 1,00 | 5 k USD |
| 2022-03-15 | Fraser Craig | President and CEO | Buy | 3 k | 0,98 | 3 k USD |
| 2022-03-15 | Simonson Steven | SVP, Chief Medical Officer | Buy | 5 k | 1,00 | 5 k USD |
| 2022-03-04 | CARMAN DIANE | SVP & General Counsel | Buy | 66 k | 0,00 | 0 USD |
| 2022-03-04 | Curtis Eric | SVP & COO | Buy | 66 k | 0,00 | 0 USD |
| 2022-03-04 | Fraser Craig | President and CEO | Buy | 167 k | 0,00 | 0 USD |
| 2022-03-04 | Hamill John P. | SVP & CFO | Buy | 66 k | 0,00 | 0 USD |
| 2022-03-04 | Simonson Steven | SVP, Chief Medical Officer | Buy | 66 k | 0,00 | 0 USD |
| 2022-03-04 | CARMAN DIANE | SVP & General Counsel | Buy | 66 k | 0,00 | 0 USD |
| 2022-03-04 | Curtis Eric | SVP & COO | Buy | 66 k | 0,00 | 0 USD |
| 2022-03-04 | Fraser Craig | President and CEO | Buy | 167 k | 0,00 | 0 USD |
| 2022-03-04 | Hamill John P. | SVP & CFO | Buy | 66 k | 0,00 | 0 USD |
| 2022-03-04 | Simonson Steven | SVP, Chief Medical Officer | Buy | 66 k | 0,00 | 0 USD |
| 2021-12-30 | Bioengine Capital Inc. | 10% owner | Sell | 1.2 mn | 1,60 | 2.0 mn USD |
| 2021-12-30 | Center Laboratories, Inc. | 10% owner | Buy | 1.2 mn | 1,60 | 2.0 mn USD |
| 2021-12-30 | Bioengine Capital Inc. | 10% owner | Sell | 1.2 mn | 1,60 | 2.0 mn USD |
| 2021-12-30 | Center Laboratories, Inc. | 10% owner | Buy | 1.2 mn | 1,60 | 2.0 mn USD |
| 2021-11-19 | Fraser Craig | President and CEO | Buy | 930 | 1,60 | 1 k USD |
| 2021-11-19 | Fraser Craig | President and CEO | Buy | 930 | 1,60 | 1 k USD |
| 2021-11-18 | Fraser Craig | President and CEO | Buy | 930 | 1,61 | 1 k USD |
| 2021-11-18 | Fraser Craig | President and CEO | Buy | 930 | 1,61 | 1 k USD |
| 2021-10-22 | Fraser Craig | President and CEO | Buy | 3 k | 1,90 | 6 k USD |
| 2021-10-22 | Fraser Craig | President and CEO | Buy | 3 k | 1,90 | 6 k USD |
| 2021-10-19 | Fraser Craig | President and CEO | Buy | 3 k | 1,91 | 6 k USD |
| 2021-10-19 | Huang James | Director | Buy | 50 k | 1,90 | 95 k USD |
| 2021-10-19 | Fraser Craig | President and CEO | Buy | 3 k | 1,91 | 6 k USD |
| 2021-10-19 | Huang James | Director | Buy | 50 k | 1,90 | 95 k USD |
| 2021-04-16 | Fraser Craig | President and CEO | Buy | 1 k | 2,09 | 2 k USD |
| 2021-04-16 | Fraser Craig | President and CEO | Buy | 1 k | 2,09 | 2 k USD |
| 2021-04-16 | Hamill John P. | SVP & CFO | Buy | 1 k | 2,07 | 2 k USD |
| 2021-04-16 | Hamill John P. | SVP & CFO | Buy | 1 k | 2,07 | 2 k USD |
| 2021-04-15 | Fraser Craig | President and CEO | Buy | 1 k | 2,24 | 2 k USD |
| 2021-04-15 | Fraser Craig | President and CEO | Buy | 1 k | 2,24 | 2 k USD |
| 2021-04-07 | Curtis Eric | SVP & COO | Buy | 791 | 2,52 | 2 k USD |
| 2021-04-07 | Curtis Eric | SVP & COO | Buy | 791 | 2,52 | 2 k USD |
| 2021-04-06 | Fraser Craig | President and CEO | Buy | 500 | 2,57 | 1 k USD |
| 2021-04-06 | Fraser Craig | President and CEO | Buy | 500 | 2,57 | 1 k USD |
| 2021-04-05 | Fraser Craig | President and CEO | Buy | 1 k | 2,58 | 3 k USD |
| 2021-04-05 | Fraser Craig | President and CEO | Buy | 1 k | 2,58 | 3 k USD |
| 2021-04-01 | Fraser Craig | President and CEO | Buy | 500 | 2,46 | 1 k USD |
| 2021-04-01 | Fraser Craig | President and CEO | Buy | 500 | 2,46 | 1 k USD |
| 2021-03-31 | Huang James | Director, 10% owner | Buy | 150 k | 2,36 | 354 k USD |
| 2021-03-31 | Huang James | Director, 10% owner | Buy | 150 k | 2,36 | 354 k USD |
| 2021-03-31 | Fraser Craig | President and CEO | Buy | 500 | 2,32 | 1 k USD |
| 2021-03-31 | Fraser Craig | President and CEO | Buy | 500 | 2,32 | 1 k USD |
| 2021-03-25 | Fraser Craig | President and CEO | Buy | 2 k | 3,25 | 5 k USD |
| 2021-03-25 | Hamill John P. | SVP & CFO | Buy | 2 k | 3,25 | 5 k USD |
| 2021-03-25 | Simonson Steven | SVP, Chief Medical Officer | Buy | 2 k | 3,25 | 5 k USD |
| 2021-03-25 | Fraser Craig | President and CEO | Buy | 2 k | 3,25 | 5 k USD |
| 2021-03-25 | Hamill John P. | SVP & CFO | Buy | 2 k | 3,25 | 5 k USD |
| 2021-03-25 | Simonson Steven | SVP, Chief Medical Officer | Buy | 2 k | 3,25 | 5 k USD |
| 2020-10-28 | Fraser Craig | President and CEO | Buy | 250 | 6,56 | 2 k USD |
| 2020-10-28 | Fraser Craig | President and CEO | Buy | 250 | 6,56 | 2 k USD |
| 2020-10-23 | Huang James | Director, 10% owner | Buy | 1 k | 6,67 | 7 k USD |
| 2020-10-23 | Huang James | Director, 10% owner | Buy | 1 k | 6,67 | 7 k USD |
| 2020-10-09 | Fraser Craig | President and CEO | Buy | 250 | 5,83 | 1 k USD |
| 2020-10-09 | Fraser Craig | President and CEO | Buy | 250 | 5,83 | 1 k USD |
| 2020-10-08 | Curtis Eric | SVP & COO | Buy | 500 | 5,27 | 3 k USD |
| 2020-10-08 | Curtis Eric | SVP & COO | Buy | 500 | 5,27 | 3 k USD |
| 2020-10-07 | Fraser Craig | President and CEO | Buy | 250 | 5,17 | 1 k USD |
| 2020-10-07 | Hamill John P. | SVP & CFO | Buy | 1 k | 5,27 | 5 k USD |
| 2020-10-07 | Fraser Craig | President and CEO | Buy | 250 | 5,17 | 1 k USD |
| 2020-10-07 | Hamill John P. | SVP & CFO | Buy | 1 k | 5,27 | 5 k USD |
| 2020-05-20 | Bioengine Capital Inc. | 10% owner | Sell | 3.6 mn | 0,00 | 0 USD |
| 2020-05-20 | Bioengine Capital Inc. | 10% owner | Buy | 55 k | 7,25 | 400 k USD |
| 2020-05-20 | Center Laboratories, Inc. | 10% owner | Sell | 3.6 mn | 0,00 | 0 USD |
| 2020-05-20 | Center Laboratories, Inc. | 10% owner | Buy | 55 k | 7,25 | 400 k USD |
| 2020-05-20 | Bioengine Capital Inc. | 10% owner | Sell | 3.6 mn | 0,00 | 0 USD |
| 2020-05-20 | Bioengine Capital Inc. | 10% owner | Buy | 55 k | 7,25 | 400 k USD |
| 2020-05-20 | Center Laboratories, Inc. | 10% owner | Sell | 3.6 mn | 0,00 | 0 USD |
| 2020-05-20 | Center Laboratories, Inc. | 10% owner | Buy | 55 k | 7,25 | 400 k USD |